HRP920575B1 - Solid oral administration forms containing ifosfamide as an active agent and a process for the production of the same - Google Patents

Solid oral administration forms containing ifosfamide as an active agent and a process for the production of the same

Info

Publication number
HRP920575B1
HRP920575B1 HRP-1342/91A HRP920575A HRP920575B1 HR P920575 B1 HRP920575 B1 HR P920575B1 HR P920575 A HRP920575 A HR P920575A HR P920575 B1 HRP920575 B1 HR P920575B1
Authority
HR
Croatia
Prior art keywords
production
active agent
same
oral administration
solid oral
Prior art date
Application number
HRP-1342/91A
Other languages
English (en)
Inventor
Otto Isaac
Original Assignee
Otto Isaac
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from YU134291A external-priority patent/YU48592B/sh
Application filed by Otto Isaac filed Critical Otto Isaac
Publication of HRP920575A2 publication Critical patent/HRP920575A2/xx
Publication of HRP920575B1 publication Critical patent/HRP920575B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HRP-1342/91A 1990-08-03 1992-09-29 Solid oral administration forms containing ifosfamide as an active agent and a process for the production of the same HRP920575B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
YU134291A YU48592B (sh) 1990-08-03 1991-08-01 Postupak za proizvodnju čvrstih, oralnih ifosfamid-preparata
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (2)

Publication Number Publication Date
HRP920575A2 HRP920575A2 (en) 1995-04-30
HRP920575B1 true HRP920575B1 (en) 1999-04-30

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP-1342/91A HRP920575B1 (en) 1990-08-03 1992-09-29 Solid oral administration forms containing ifosfamide as an active agent and a process for the production of the same

Country Status (33)

Country Link
US (1) US5158776A (no)
EP (1) EP0469440B1 (no)
JP (2) JP3061898B2 (no)
KR (1) KR0177170B1 (no)
CN (1) CN1046851C (no)
AR (1) AR247484A1 (no)
AT (1) ATE110261T1 (no)
AU (2) AU643309B2 (no)
BG (1) BG60900B1 (no)
CA (1) CA2048367C (no)
CZ (1) CZ280475B6 (no)
DE (2) DE4124481A1 (no)
DK (1) DK0469440T3 (no)
EG (1) EG19690A (no)
ES (1) ES2058999T3 (no)
FI (1) FI97951C (no)
HK (1) HK15695A (no)
HR (1) HRP920575B1 (no)
HU (1) HU206268B (no)
IE (1) IE66378B1 (no)
IL (1) IL99031A (no)
LT (1) LT3528B (no)
LV (1) LV10043B (no)
MC (1) MC2274A1 (no)
MX (1) MX9100441A (no)
NO (1) NO178252C (no)
NZ (1) NZ239222A (no)
PT (1) PT98532B (no)
RO (1) RO113611B1 (no)
SG (1) SG181694G (no)
SI (1) SI9111342B (no)
SK (2) SK279740B6 (no)
ZA (1) ZA916124B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0804174A4 (en) * 1993-07-21 1998-09-09 Univ Kentucky Res Found MULTI-CHAMBER HARD CAPSULES WITH CONTROLLED DELIVERY CHARACTERISTICS
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
CN106413706A (zh) 2014-01-06 2017-02-15 铁治疗控股公司 三麦芽酚铁的剂量方案
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
DE3722043A1 (de) * 1986-07-11 1988-01-14 Asta Werke Ag Chem Fab Loesungen von oxazaphosphorinen mit verbesserter stabilitaet und verfahren zu deren herstellung
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
CZ280475B6 (cs) 1996-01-17
SK279740B6 (sk) 1999-03-12
AR247484A1 (es) 1995-01-31
JP3545300B2 (ja) 2004-07-21
IE912774A1 (en) 1992-02-12
SK279739B6 (sk) 1999-03-12
CS240991A3 (en) 1992-03-18
AU8158991A (en) 1992-02-06
HK15695A (en) 1995-02-10
MC2274A1 (fr) 1993-06-23
NO178252B (no) 1995-11-13
IE66378B1 (en) 1995-12-27
ATE110261T1 (de) 1994-09-15
MX9100441A (es) 1992-04-01
HU912594D0 (en) 1992-01-28
LV10043B (en) 1995-06-20
JPH04243828A (ja) 1992-08-31
NO178252C (no) 1996-02-21
PT98532B (pt) 1999-01-29
DE4124481A1 (de) 1992-02-06
AU4483693A (en) 1993-11-11
LV10043A (lv) 1994-05-10
AU649184B2 (en) 1994-05-12
KR0177170B1 (ko) 1999-03-20
NO913019L (no) 1992-02-04
HRP920575A2 (en) 1995-04-30
DE59102620D1 (de) 1994-09-29
PT98532A (pt) 1992-06-30
IL99031A (en) 1996-09-04
HU206268B (en) 1992-10-28
IL99031A0 (en) 1992-07-15
SI9111342B (sl) 1998-10-31
CN1058715A (zh) 1992-02-19
AU643309B2 (en) 1993-11-11
DK0469440T3 (da) 1994-11-14
KR920003963A (ko) 1992-03-27
CN1046851C (zh) 1999-12-01
LT3528B (en) 1995-11-27
FI913710A (fi) 1992-02-04
FI913710A0 (fi) 1991-08-02
US5158776A (en) 1992-10-27
CA2048367C (en) 2000-05-23
ES2058999T3 (es) 1994-11-01
HUT59316A (en) 1992-05-28
EG19690A (en) 1995-09-30
ZA916124B (en) 1992-04-29
CA2048367A1 (en) 1992-02-04
NO913019D0 (no) 1991-08-02
SG181694G (en) 1995-05-12
RO113611B1 (ro) 1998-09-30
LTIP921A (en) 1995-03-27
EP0469440A1 (de) 1992-02-05
FI97951C (fi) 1997-03-25
EP0469440B1 (de) 1994-08-24
NZ239222A (en) 1993-01-27
BG60900B1 (bg) 1996-06-28
FI97951B (fi) 1996-12-13
JP2000229860A (ja) 2000-08-22
JP3061898B2 (ja) 2000-07-10
SI9111342A (sl) 1998-04-30

Similar Documents

Publication Publication Date Title
HUT41642A (en) Process for producing tablets of regulated dissolution of the active agents
GB2143734B (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
HUT47552A (en) Process for producing 10-dihydro-10-deoxo-11-aza-erythronolid a derivatives and pharmaceutical compositions containing them as active components
HUT46028A (en) Process for producing pharmaceutical compositions containing oligosaccharides as active components and for producing the active components
HUT57202A (en) Process for producing new pharmaceutically active 5-fluoro-2-///4-/cyclopropyl-methoxy/-2-pyridinyl/-methyl-sulfonyl/-1h-benzimidazol and pharmaceutical compositions containing them
HUT50339A (en) Process for producing benzoxazole derivatives and pharmaceutical compositions comprising the compounds
HUT51222A (en) Process for producing 9-halogen-/z/-prostaglandin derivatives and pharmaceutical compositions comprising such active ingredient
HUT37781A (en) Process for producing 1-fluorphenyl-butyl-4-/2-pirimidinyl/-piperazine derivatives and pharmaceutical compositions containing them as active agents
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
HUT48269A (en) Process for producing pharmaceutically active nukleozide and pharmaceutical compositions containing them
HUT48247A (en) Process for producing aza-bicyclo-octyl-ether derivatives and pharmaceutical compositions containing them as active components
HUT49494A (en) Process for producing active component of pharmaceutical compositions
HUT41957A (en) Insecticide compositions containing aryl-pyridon derivatives as active agents and process for producing the active agents
HUT51596A (en) Process for production of the active substance of the medical composition levodopa
HRP920575B1 (en) Solid oral administration forms containing ifosfamide as an active agent and a process for the production of the same
HUT48251A (en) Process for producing new xantin derivatives and pharmaceutical compositions containing them as active components
HUT41784A (en) Process for producing 1,8-naphtiridine derivatives and pharmaceutical compositions containing them as active agents
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
HUT43848A (en) Process for producing pyridinyl-piperazine derivatives and pharmaceutical compositions containing them as active agents
HUT39437A (en) Process for producing new morpholinol derivatives and pharmaceutical compositions containing them as active agents
HUT49807A (en) Process for production of medical compositions and the active substance
HUT50762A (en) Process for production of medical compositions containing as active substance derivatives of pirrol and process for production of the active substance
HUT41757A (en) Process for producing pharmaceutical compositions containing e-desmethyl-mevalonic acid derivatives and process for producing the active agents
HU896122D0 (en) Process for the formation of active agents for waxed tablets
HUT60711A (en) Process for producing new crystalline (s)-norfluoxetine and pharmaceutical composition comprising the active ingredient

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: ASTA MEDICA AKTIENGESELLSCHAFT, DE

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040721

Year of fee payment: 14

PBON Lapse due to non-payment of renewal fee

Effective date: 20050802